Scott Dunseth Myers - Nov 27, 2023 Form 4 Insider Report for Harpoon Therapeutics, Inc. (HARP)

Role: Director
Signature: /s/ Frank J. Lanza, Attorney-in-Fact
Stock symbol: HARP
Transactions as of: Nov 27, 2023
Transactions value $: $0
Form type: 4
Date filed: 11/28/2023, 04:26 PM
Previous filing: Nov 15, 2023
Next filing: Jan 3, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	HARP	Common Stock	Award	$0	+5K	+32.01%	$0.00	20.6K	Nov 27, 2023	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents shares of common stock issuable upon the settlement of restricted stock units ("RSUs"). 25% of the RSUs will vest on each May 27th and November 27th of 2024 and 2025, subject to acceleration and vesting in full upon a Change in Control (as defined in the Issuer's 2019 Equity Incentive Plan) of the Issuer, and subject to the continuing employment of the Reporting Person on each vesting date.

Content

Represents shares of common stock issuable upon the settlement of restricted stock units ("RSUs"). 25% of the RSUs will vest on each May 27th and November 27th of 2024 and 2025, subject to acceleration and vesting in full upon a Change in Control (as defined in the Issuer's 2019 Equity Incentive Plan) of the Issuer, and subject to the continuing employment of the Reporting Person on each vesting date.